(Reuters) – The U.S. Food and Drug Administration said on Friday that an advisory panel of its experts would hold meetings later this month to discuss authorizing booster doses of Moderna Inc and Johnson & Johnson’s COVID-19 vaccines.
(Reporting by Manas Mishra in Bengaluru; Editing by Amy Caren Daniel)
